All news

Labcorp closes $375 million deal with 4.8% upside to target

Alpha Vantage · Simply Wall St · · AI-summarised by FinFlash

Labcorp Holdings has returned 80.6% to shareholders over three years and recently completed a US$375 million acquisition of Millennium Health, expanding its toxicology testing capabilities. The stock trades at a P/E of 30.0x, above the healthcare sector average, which analysts say matches its growth drivers and risk profile. Recent insider share sales raise questions about management's actions.

Read original source

LH company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.